Preceding dyspepsia (n=8) | No dyspepsia (n=48) | ||
---|---|---|---|
Median age (range) | 73 (62–90) | 77 (44–92) | p=0.519 (Mann–Whitney test) |
Sex | |||
Female | 4 | 11 | p=0.190 (Fisher's exact test) |
Male | 4 | 37 | |
Cancer | |||
Oesophageal | 4 | 30 | p=0.698 (Fisher's exact test) |
Gastric | 4 | 18 | |
GP visits | |||
Single | 4 | 31 | p=0.431 (Fisher's exact test) |
Multiple | 4 | 15 | |
ASM use | |||
Yes | 5 | 17 | p=0.260 (Fisher's exact test) |
No | 3 | 27 | |
Mean delay to referral, days (SD) | 8 (10.8) | 16 (26.0) | p=0.670 (Mann–Whitney test) |
Tumour stage | |||
≤T3NxM0 | 4 | 28 | p=0.436 (Fisher's exact test) |
>T3NxM0 | 4 | 14 | |
Median length of survival, days (range) | 709 (46–1834) | 264 (8–2022) | p=0.325 (Mann–Whitney test) |
ASM, acid suppression medication (proton pump inhibitors or H2 receptor antagonists).